b12 Labs
ActiveAI-nativeMaking hard molecules for Pharma and Biotech
What it does
b12 makes high-value molecules that are otherwise hard to make. We help pharma companies plan and make new drugs, accelerating early-stage drug discovery from years to months. Andres built the first AI agent that can autonomously think and make molecules in a robotic lab, published in Nature Machine Intelligence (1000+ citations), and won the best paper award at the NeurIPS AI for Science conference. Zlatko is a 3x National Chemistry Olympiad champion, competed at IChO level, and medicinal chemist who has worked at Roche and leading lab robotics companies. Combined, we have an extensive network of hundreds of chemists, automation scientists, and AI 4 Science researchers. We run paid pilots with big pharma companies, demonstrating that our platform planned a set of experiments that achieved full conversion in a single attempt, eliminating the iteration cycle.
Its site says now · captured 2026-08-23
b12 labs
AI-powered chemical synthesis platform. Plan complex routes, design experiments, and automate lab workflows.
Next to it in Healthcare and bio · AI-driven molecule synthesis and drug discovery
- Junction BioscienceY Combinator W24
AI Hypothesis Engine for Molecular Discovery
- ConvexiaY Combinator S25
The world's first AI-maximalist pharma company
- RasynY Combinator S26
Towards a General Intelligence for Chemistry
- WonderTxY Combinator S26
Extrapolative AI to unlock First-in-Class drugs
- PaulingPlug and Play PnP 2025
Next-generation molecular simulation platform for drug discovery.
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
- Anto BiosciencesY Combinator F25
A Foundation Model for Microbial Communities.
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.